glycylsarcosine has been researched along with ibuprofen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Brodin, B; Nielsen, CU; Omkvist, DH | 1 |
Imakura, Y; Iwao, T; Kabeya, T; Matsunaga, T; Mima, S; Miyashita, T; Ogura, I; Yamada, T; Yasujima, T; Yuasa, H | 1 |
3 other study(ies) available for glycylsarcosine and ibuprofen
Article | Year |
---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Topics: Animals; Biological Transport; Caco-2 Cells; Cell Line; Cell Line, Transformed; Dipeptides; Dogs; Drug Interactions; Glycine; Humans; Ibuprofen; Methylglucosides; Peptide Transporter 1; Symporters | 2010 |
Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells.
Topics: Alkanesulfonic Acids; Caco-2 Cells; Cells, Cultured; Cyclosporins; Digoxin; Dipeptides; Epithelial Cells; Humans; Ibuprofen; Induced Pluripotent Stem Cells; Intestine, Small; Morpholines | 2020 |